1. Home
  2. LEGN vs LITE Comparison

LEGN vs LITE Comparison

Compare LEGN & LITE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • LITE
  • Stock Information
  • Founded
  • LEGN 2014
  • LITE 2015
  • Country
  • LEGN United States
  • LITE United States
  • Employees
  • LEGN N/A
  • LITE N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • LITE Telecommunications Equipment
  • Sector
  • LEGN Health Care
  • LITE Telecommunications
  • Exchange
  • LEGN Nasdaq
  • LITE Nasdaq
  • Market Cap
  • LEGN 5.4B
  • LITE 4.6B
  • IPO Year
  • LEGN 2020
  • LITE N/A
  • Fundamental
  • Price
  • LEGN $28.95
  • LITE $72.28
  • Analyst Decision
  • LEGN Strong Buy
  • LITE Buy
  • Analyst Count
  • LEGN 12
  • LITE 15
  • Target Price
  • LEGN $77.09
  • LITE $79.73
  • AVG Volume (30 Days)
  • LEGN 1.9M
  • LITE 2.6M
  • Earning Date
  • LEGN 05-13-2025
  • LITE 05-06-2025
  • Dividend Yield
  • LEGN N/A
  • LITE N/A
  • EPS Growth
  • LEGN N/A
  • LITE N/A
  • EPS
  • LEGN N/A
  • LITE N/A
  • Revenue
  • LEGN $728,303,000.00
  • LITE $1,472,600,000.00
  • Revenue This Year
  • LEGN $64.21
  • LITE $21.62
  • Revenue Next Year
  • LEGN $53.69
  • LITE $28.19
  • P/E Ratio
  • LEGN N/A
  • LITE N/A
  • Revenue Growth
  • LEGN 112.46
  • LITE 3.58
  • 52 Week Low
  • LEGN $27.34
  • LITE $38.29
  • 52 Week High
  • LEGN $60.87
  • LITE $104.00
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.56
  • LITE 53.45
  • Support Level
  • LEGN $28.13
  • LITE $73.59
  • Resistance Level
  • LEGN $29.31
  • LITE $80.00
  • Average True Range (ATR)
  • LEGN 1.63
  • LITE 2.89
  • MACD
  • LEGN 0.03
  • LITE -0.41
  • Stochastic Oscillator
  • LEGN 27.01
  • LITE 28.12

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About LITE Lumentum Holdings Inc.

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

Share on Social Networks: